✦ LIBER ✦

Autologous lymph node cell-derived tumor-specific cytotoxic t-cells for use in adoptive immunotherapy of human melanoma

✍ Scribed by Timothy L. Darrow; Craig L. Slingluff; Hilliard F. Seigler

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 820 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880701)62:1<84::aid-cncr2820620116>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo eradication of an established hu

In vivo eradication of an established human melanoma by an in vitro generated autologous cytotoxic T cell clone: A SCID use model

✍ Anna Catharina Olsen Stenholm; Alexei F. Kirkin; Jesper Zeuthen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB 👁 2 views

Differences in the recognition of tumor-

Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer

✍ Koji Kono; Fumiko Ichihara; Hidehiko Iizuka; Takayoshi Sekikawa; and Yoshirou Ma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 2 views

We established gastric cancer-specific CD8 1 T-cell (T CD8 1) lines derived from different lymphocyte sources in the same patients by repeated stimulation with mitomycin-C-treated autologous tumor cells with low-dose interleukin-2, and we compared recognition patterns among the T CD8 1 derived from

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix